MicroPort® Scientific India Attends Annual Arthroplasty Conference Hyderabad

Hyderabad, India – From February 24 to February 25, MicroPort® Scientific India attended the Annual Arthroplasty Conference Hyderabad in India with more than 400 orthopedic surgeons from worldwide in attendance. MicroPort® Scientific India displayed MicroPort® Orthopedics products and attracted wide attention from the audience with its SuperPath® Micro-posterior Total Hip Arthroplasty ("SuperPath®") and ADVANCE® Total Knee Replacement System ("ADVANCE®").
On February 24, during the session of "Hip Surgical Technique", Australian orthopedic expert Dr. Sol Qurashi delivered a speech of "posterior approach – SuperPath®". He pointed out, SuperPath® features early healing, less intraoperative blood loss, and fast postoperative recovery. Meanwhile, Dr. Sol Qurashi completed a live hip replacement surgery with SuperPath®. The surgery achieved successful result and the advantages of SuperPath® won high recognition from the audience.
On the same day, MicroPort® Scientific India hosted a training course about the design rationale of ADVANCE®. Dr. Sanjay from Indian hospital Kokilaben hospital Mumbai demonstrated the design rationale and clinical application of ADVANCE®. After the demonstration, the surgeons were allowed to try implanting ADVANCE® one by one, and most of them spoke highly of the excellent performance of ADVANCE® as it is more stable compared to traditional PS knees.
Since the establishment of MicroPort® Scientific India in 2016, it has introduced Firehawk® Rapamycin Target Eluting Coronary Stent System ("Firehawk®") and Firefighter™ PTCA Balloon Catheter ("Firefighter™") to the India market. With the increasing awareness of MicroPort® brand in the local market, its cardiovascular products are gaining higher recognition among patients and physicians in India. As a country with the second largest population, India has a fast growing orthopedic market. According to statistics, in 2016 the market value of Indian orthopedic implant stood at USD375 million with an annual growth rate of 20% from 2017 to 2020. The appearance of MicroPort® Scientific India in the First Hyderabad Arthroplasty Meeting was reported by several local media such as The Hans India, Surya, The Hindu Business Line, Aadab Hyderabad. With the expansion of the orthopedic business in India, it is expected that the market share and brand awareness of MicroPort® will be further increased in India and other overseas market.